Global Health Management
Management criteria checks 3/4
Global Health's CEO is Alumootil Mathew Cherian, appointed in Nov 2022, has a tenure of 1.42 years. total yearly compensation is A$374.40K, comprised of 73.2% salary and 26.8% bonuses, including company stock and options. directly owns 41.65% of the company’s shares, worth A$2.78M. The average tenure of the management team and the board of directors is 1.7 years and 6.6 years respectively.
Key information
Alumootil Mathew Cherian
Chief executive officer
AU$374.4k
Total compensation
| CEO salary percentage | 73.2% |
| CEO tenure | 1.4yrs |
| CEO ownership | 41.6% |
| Management average tenure | 1.7yrs |
| Board average tenure | 6.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$6m |
| Sep 30 2023 | n/a | n/a | -AU$7m |
| Jun 30 2023 | AU$374k | AU$274k | -AU$8m |
| Mar 31 2023 | n/a | n/a | -AU$6m |
| Dec 31 2022 | n/a | n/a | -AU$3m |
| Sep 30 2022 | n/a | n/a | -AU$3m |
| Jun 30 2022 | AU$395k | AU$330k | -AU$2m |
| Mar 31 2022 | n/a | n/a | -AU$2m |
| Dec 31 2021 | n/a | n/a | -AU$2m |
| Sep 30 2021 | n/a | n/a | -AU$1m |
| Jun 30 2021 | AU$486k | AU$253k | -AU$488k |
| Mar 31 2021 | n/a | n/a | -AU$173k |
| Dec 31 2020 | n/a | n/a | AU$142k |
| Sep 30 2020 | n/a | n/a | -AU$29k |
| Jun 30 2020 | AU$286k | AU$212k | -AU$200k |
| Mar 31 2020 | n/a | n/a | -AU$751k |
| Dec 31 2019 | n/a | n/a | -AU$1m |
| Sep 30 2019 | n/a | n/a | -AU$1m |
| Jun 30 2019 | AU$291k | AU$222k | -AU$1m |
| Mar 31 2019 | n/a | n/a | -AU$1m |
| Dec 31 2018 | n/a | n/a | -AU$1m |
| Sep 30 2018 | n/a | n/a | -AU$2m |
| Jun 30 2018 | AU$270k | AU$213k | -AU$2m |
| Mar 31 2018 | n/a | n/a | -AU$2m |
| Dec 31 2017 | n/a | n/a | -AU$3m |
| Sep 30 2017 | n/a | n/a | -AU$655k |
| Jun 30 2017 | AU$307k | AU$269k | AU$2m |
Compensation vs Market: Alumootil Mathew's total compensation ($USD243.61K) is about average for companies of similar size in the Australian market ($USD292.58K).
Compensation vs Earnings: Alumootil Mathew's compensation has been consistent with company performance over the past year.
CEO
Alumootil Mathew Cherian (66 yo)
1.4yrs
Tenure
AU$374,397
Compensation
Mr. Alumootil Mathew Cherian, B.Bus. (IS/IT), MACS, MAICD, had been the Chief Executive Officer and Managing Director of Global Health Ltd. (Formerly Working Systems Solutions Ltd.) since January 2002 unti...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group MD & Executive Director | 1.4yrs | AU$374.40k | 41.65% A$ 2.8m | |
| Chief Technology Officer | no data | AU$287.60k | 0.52% A$ 35.0k | |
| Chief Strategy Officer | no data | AU$332.98k | no data | |
| Chief Information Officer | 3yrs | no data | no data | |
| Vice President of Investor Relations | 2.4yrs | no data | no data | |
| Regional Chief Executive of Asia Pacific in Singapore- Asia Pacific Focus | 1.7yrs | no data | no data | |
| Company Secretary | 1.3yrs | no data | no data |
1.7yrs
Average Tenure
Experienced Management: GLH's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group MD & Executive Director | no data | AU$374.40k | 41.65% A$ 2.8m | |
| Independent Non-Executive Chairman | 23.3yrs | AU$61.66k | 0.75% A$ 50.0k | |
| Independent Non-Executive Director | 10.6yrs | AU$64.64k | 0.84% A$ 56.0k | |
| Independent Non-Executive Director | 2.7yrs | AU$49.73k | 0.069% A$ 4.6k | |
| Independent Non-Executive Director | 1.8yrs | AU$38.31k | 0.060% A$ 4.0k |
6.6yrs
Average Tenure
66yo
Average Age
Experienced Board: GLH's board of directors are considered experienced (6.6 years average tenure).